Accelerating Therapies for Refractory SJIA Patients


This research study aims to learn more about the causes of Systemic Juvenile Idiopathic Arthritis (sJIA) including its complications such as Macrophage Activation Syndrome (MAS) and sJIA associated lung disease and identify new therapeutic targets. The study is asking for biological samples from those diagnosed with sJIA as well as their family members.

I'm interested

Male or Female
Up to 18 years old
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• at least 6 months old
• new onset SJIA or established SJIA with or without lung and/or liver complications
• parent or sibling of the enrolled child will also be asked to participate
Exclusion Criteria:

• illness sufficient to prohibit study participation
• inability to cooperate with the study

Arthritis & Rheumatic Diseases, Rare Diseases

SJIA, Systemic Juvenile Idiopathic Arthritis

Mona Riskalla -
Mona Riskalla